<DOC>
	<DOCNO>NCT00145470</DOCNO>
	<brief_summary>This 12-week study test safety efficacy asenapine use addition lithium valproate subject acute manic mixed episode Bipolar I Disorder .</brief_summary>
	<brief_title>12 Week Study Safety/Efficacy Asenapine When Added Lithium/Valproate Treatment Bipolar Disorder ( A7501008 ) ( COMPLETED ) ( P05844 )</brief_title>
	<detailed_description />
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Asenapine</mesh_term>
	<criteria>Have bipolar I disorder , current episode manic mixed Treated lithium valproic acid Have unstable medical condition Clinically significant laboratory abnormality . Have primary diagnosis bipolar I disorder .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>